Compare Cassava Sciences Inc (FLNA) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Packaging Corporation of America — how do they compare? Cassava Sciences Inc trades at $1.1 (market cap $53.14M), while Packaging Corporation of America trades at $233.91 (market cap $20.30B). The key difference: Packaging Corporation of America is far larger — about 382× Cassava Sciences Inc's market cap, and Packaging Corporation of America pays a 2.63% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | PKG | |
|---|---|---|
Market Cap | $53.14M | $20.30B |
Sector | Health | Technology |
52-Week High | $4.64 | $246.31 |
52-Week Low | $1.09 | $191.41 |
Enterprise Value | -$33.43M | $24.13B |
Dividend Yield | — | 2.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Packaging Corporation of America (PKG) trades at $231.26, up 2.44% on the day, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating Q1 2026 estimates but missing Q3 and Q4 2025. Fundamentals show solid profitability with an 8.04% net margin and 16.21% ROE, though valuation ratios appear elevated. The company recently announced a 20% dividend increase, signaling confidence in cash generation.
The outlook is cautiously optimistic, supported by analyst consensus and a dividend hike, but tempered by recent earnings misses and margin pressure. Key opportunities include market share gains and operational efficiency, while risks involve input cost inflation, competitive pressures, and potential earnings volatility. The stock trades below the consensus price target of $256.14, suggesting potential upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
